Peer-reviewed article

Response to: Commentary on "Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study".

Reif A iD, Anıl Yağcıoğlu AE, Bitter I, Buyze J, Frey R, Fu DJ, Godinov Y, Haggström L, Kambarov Y, Nielsen RE, Oliveira-Maia AJ, von Holt C, Young AH iD, Cubała WJ iD

European neuropsychopharmacology : the journal of the European College of NeuropsychopharmacologyJun 5, 2026Germany, Belgium, Austria, United States, Sweden, Denmark, Portugal, United Kingdom, Poland0 citationsDOI: 10.1016/j.euroneuro.2026.112885

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Pharmacologic Approaches to Suicide Prevention.

Zisook S, Domingues I, Compton J

Europe PMC2023

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.

Hossein S, Rengasamy M, Uzamere A +5

Europe PMC2025